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Abstract We report isolation of a murine gene, NPYR-D, 
which predicts an intronless novel G protein-coupled receptor of 
375 amino acids. Percent identities of NPYR-D to the cloned Y1, 
Y2, rat Y4/PP1 and human Y4/PP1 receptors are 45, 32, 92 and 
76, respectively. Southern blots indicate that NPYR-D and 
human Y4/PP1 receptor genes are species homologues. Rat 
[12~I]pancreatic polypeptide ([leSI]rPP) bound to NPYR-D- 
transfected COS-7 cell membranes with a high affinity, i.e. 
IC50=90 pM. Pharmacological characterization of [a25I]rPP 
binding showed a rank order of potency of PP >> PYY -> NPY, 
such that PYY and NPY were at least 5000-fold weaker than 
PP. Interestingly, [125I]rPYY binding produced the same rank 
order, but PYY and NPY were only 25-fold weaker than PP, 
which had an IC~0 value of approximately 120 pM. Tissue 
distribution studies in mouse and humans suggest potential roles 
of this novel receptor in the gastrointestinal tract, heart, prostate, 
as well as in neural and endocrine signalling. 
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gastric motility in rats [9,10]. In addition, PP binding sites 
have been described in other peripheral tissues, e.g. in the 
adrenal gland and liver [11,12]. 
Pancreatic polypeptides produce their effects through inter- 
action at multiple receptors. Pharmacological nd physiologi- 
cal studies have described several different NPY receptor sub- 
types, i.e. Y1, Y2, Y3, as well as a PP receptor [1-4,7,12]. 
Molecular cloning and characterization of the Y1 subtype of 
NPY receptors demonstrated that it is a member of the super- 
family of G protein coupled receptors [13-15]. Very recently, 
during the course of this work, cloning and characterization 
of Y2, Y4 and PP1 receptors has also been reported [lf~20]. 
In this report we describe cloning of a mouse gene encoding 
a novel member of the neuropeptide Y receptor family, 
NPYR-D.  We show that this receptor has very high affinity 
for PP and that it is highly homologous to human and rat Y4/ 
PP1 receptors [17,19,20]. We also describe pharmacological 
properties of recombinant NPYR-D receptors expressed in 
COS-7 cells, and regional distribution of this novel receptor 
in mouse and human tissues. 
I. Introduction 2. Materials and methods 
Pancreatic polypeptide (PP), neuropeptide Y (NPY) and 
peptide YY (PYY) belong to a family of structurally related 
36-amino-acid peptides which have functions in both neural 
and endocrine signalling [1-4]. Among these pancreatic poly- 
peptides, NPY is the most prominent, having potent biologi- 
cal effects on many targets in the brain and periphery. NPY is 
known to regulate central and peripheral nervous systems, 
cardiovascular activity, and neuroendocrine axis including re- 
production and food intake [1-4]. 
Relatively little is known about the functional significance 
of PP, a hormone released from certain endocrine cells of 
pancreatic islets after meals [5,6]. PP is also found in endo- 
crine cells of the gastrointestinal tract, and functional PP re- 
ceptors in small intestine and colon have been described [5 7]. 
All three pancreatic polypeptides are present in the general 
circulation. The permeability of the blood-brain barrier al- 
lows circulating PP in physiological concentrations to bind 
to brainstem PP receptors in area postrema, interpenduncular 
nucleus, dorsomedial nucleus and nucleus tractus solitarius 
[8]. Centrally administered PP acting in brainstem nuclei can 
inhibit pancreatic secretion and stimulate gastric secretion and 
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Library screening, cloning, sequencing and other manipulations 
were carried out by standard methods [21]. Mouse 129SV genomic 
library (gift of Dr. Ann Davis) was custom constructed in phage 
lambda Fix II by Stratagene. Sequence of a 53-mer oligonucleotide 
probe corresponding to TM7 of cloned NPY receptors, was as fol- 
lows: 5'-AAG CCA TAA AAT ATG GGG TTI ACA CAI GTG 
GAI ATC ATI GCI RYI AGG TGG CA-3' (I =inosine). About 
800,000 recombinant phages were screened with the radiolabeled oli- 
gonucleotide probe. Hybridizations were at 42°C in 5x SSPE ( lz  
SSPE=150 mM NaC1, 10 mM NaH2PO4, 1 mM EDTA), 0.1% 
SDS, 2x Denhardt's olution, 250 gg/ml herring sperm DNA, 125 
gg/ml hydrolysed yeast RNA and 2x 10 7 cprn/ml of radiolabelled 
probe; membranes were washed 2x for 30 min at 60°C in 2x SSPE 
and 0. l°S, SDS. Filters were then exposed to Kodak XAR5 film for 2- 
11 days. 14 positive phages were plaque purified and two of these 
(MM37 and MM51) were selected for detailed analysis by restriction 
mapping, Southern blotting, subcloning and sequencing. A 6 kb XbaI/ 
Notl fragment of phage MM37 was subcloned into pSK Bluescript 
(Stratagene) and found to contain the entire coding region of the 
NPYR-D gene (Genbank Data Library accession umber U40189). 
Southern blots of genomic DNA digested with EcoRI and BamHl 
were purchased from Bios Labs (New Haven, CT). Mouse NPYR-D 
probe (which consisted of a 1.2 kb DNA corresponding to the entire 
coding region) was radiolabeled by random priming and hybridized at 
37°C in 5x SSPE, 29% formamide, 0.5% SDS, 2x Denhardt's, 
100 gg/ml herring sperm DNA, and 4x 10 7 cpm/ml of radiolabelled 
probe. Blots were washed at 50°C in 0.1 z SSPE, 0.5% SDS for 2x 30 
min and exposed for 40 h. Human Y4/PP1 receptor DNAs were 
obtained independently by PCR with degenerate oligonucleotide pri- 
mers and subsequent screening of a small intestine cDNA library 
(data not shown). The human Y4/PP1 receptor probe consisted of a 
0.6 kb Pstl fragment containing the coding region after TMV and 
about 0.2 kb of 3' untranslated region. 
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Multiple tissue Northern blots were purchased from Clontech Labs 
(Palo Alto, CA). Mouse and human probes were as described above 
for Southern blots. Following prehybridization, membranes were hy- 
bridized at 42°C in 5× SSPE, 50% formamide, 0.5% SDS, 2× Den- 
hardt's, 100 lag/ml herring sperm DNA, and 4× 107 cpm/ml of radi- 
olabelled DNA probe. Membranes were washed 2× for 30 min at 
54°C in 0.1× SSPE and 0.5% SDS. Filters were then exposed to 
Kodak XAR5 film for 2-12 days. A human lS-actin cDNA was 
used to probe all filters to control for unequal oading or transfer. 
For RT-PCR, human poly(A)-containing RNA from various tis- 
sues (Clontech Labs) was reverse transcribed and resulting cDNAs 
were used for PeR with the following primers: F19R, 5'-CCA 
TGG CAA GCA AGT GGC ACA C-3' and F19F, 5'-CTC TGC 
ATG TGT TCA ACA GCC TG-3'. The PCR product of 99 bp 
was resolved on 1.5%o agarose gels and confirmed by Southern blot 
analysis. 
-203 ATGC C TGCC TCTTAC C TTAAGCCTTGTATGATAGCC TCCAATGCCAT GAGATATAAGCAG 
-143 C CAAGAACCTTTTC C C TTGC C CTTATCGTTACCTGGTTC CATTGTAGATGCATGG TCCTT 
-83 GAGTTCCATTTGTTTGTTTT  GCAGGC TGCATCTC TGAAGTAGGC CCTTT&C TCCTGGAGT 
-23 TCCCGGATC TTC TCACAC C TACCATGAATACCTC TCATTTCTTGGCC CCTC TC TTCCCAG 
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278 TC TGC CAAC CAC TCACAGTCAC CTACAC CATCATGGATTAC TGGATCTTTGGTGAAGTCC 
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338 TTTGCAAGATGTTAACTTTCATC CAGTG TATGTCAGTGACAGTCTCCATC C TC TCAC TGG 
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398 TeCTTGTGGC CC TGGAGAGACAC CAGCTCATTATCAATCCAACAGGC TGGAAAe C CAGTA 
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184 ~ 0 
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174 * ~ A N S T L N D L F H Y N H S K V V E 
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658 TC TATAC CAC C TTTCTGC TGC TCTTTCAGTAC TGCATCC CTCTAGCC TTCATC CTGGTCT 
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998 T CAAGGCTC TGGTG C T GACC TGC CATTGCAGGTC ACC TCAAGGGGAG TC TGAGCATCTGC 
1058 C CCTGTC CAC TGTTCACACGGACC TC TC CAAGGGATC GATGAG GATGGGTAGCAAGTCTA 
354 L S T V H T D L S K G S M R M G S K S N 
# 
1118 ACTTCATATAG TTGTGTC TGGG CTTTTC CC TAC C ATTTTTTTTGACACATC CTTTCACTT 
374 F I 
1178 AGTTAAGAAGACACATTGCAGGC TGTGATAGCATC C TGTCATTTC TGGC TTTTGGGG CC C 
1238 AGATAGGTTGGCAAGAGACTTGAAGC TTGGCATTCAGATGGTTTAGC CCTTTGC TGA 
Fig. 1. The nucleotide sequence and the deduced amino acid se- 
quence of the coding region of the mouse NPYR-D gene. The N- 
terminus of the protein is numbered +1 and the seven putative 
transmembrane domains (TMI TM7) are indicated by shading. Po- 
tential sites for N-linked glycosylation (*) and phosphorylation by 
protein kinase C ( ) are indicated. The nucleotide sequence of the 
1500 bp NPYR-D has been submitted to Genbank Data Library 
under accession umber U40189. 
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Fig. 2. Alignment of the deduced amino acid sequence of the mouse 
NPYR-D (mYD) with the sequences of rat Y4/PP1 receptor (rY4), 
human Y4/PP1 receptor (hY4), human Y1 receptor (hY1) and hu- 
man Y2 receptor (hY2) [14-20]. Amino acid residues identical to 
the mouse NPYR-D sequence are indicated by shading and the se- 
ven putative transmembrane domains are boxed. 
[125I]Rat pancreatic polypeptide ([125I]rPP) and [125I]rat peptide YY 
([125I]pYY) were purchased from NEN-DuPont (Boston, MA). PYY, 
NPY and (2 36)NPY were synthesized by Bayer Corp. Rat pancreatic 
polypeptide (rPP), human pancreatic polypeptide (hPP), and (Leu 3L 
Pro34)NpY were purchased from Penisula Laboratories Inc. (Bel- 
mont, CA). COS-7 cells (ATCC) were grown in DMEM media sup- 
plemented with 2 mM glutamine, 10% fetal bovine serum, 1 mM 
sodium pyruvate and antibiotic/antimycotic. Cells at 70% confluency 
were transfected with plasmids using the lipofectamine method (GIB- 
CO-BRL). The coding region of NPYR-D was cloned into pcDNA3 
(Invitrogen, San Diego, CA) to generate xpression vector pG25. 15 
lag DNA and 90 lal of lipofectamine were added to each flask. Media 
was completely replaced 24 h post transfection, and membranes were 
harvested 24 h later. The binding assays were performed on GF/C 
Millipore 96-well plates pretreated with 0.02% polyethylenimine (PEI) 
for at least 2 h prior to use. The PEI was aspirated from the plates on 
a vacuum manifold immediately before the samples were added to the 
wells. All peptides, tissue and radioligands were diluted with binding 
buffer (137 mM NaC1, 5.4 mM KC1, 0.44 mM KH2PO4, 1.26 mM 
CaCI2, 0.81 mM MgSO4, 20 mM HEPES, 1 mM DTT, 0.1% baci- 
tracin, 100 mg/ml streptomycin sulfate, 1 mg/ml aprotinin and 10 mg/ 
ml soybean trypsin inhibitor, pH 7.4, with 0.3% BSA). Samples for 
binding consisted of 1-50 lag of protein, 25 pM [a25I]rPP or 50 pM 
[125I]PYY, and peptide dilution in a final volume of 200 lal. Non- 
specific binding was defined by 1 /AM rPP or 1 laM PYY, respectively. 
After a 2 h incubation at room temperature with constant mixing, the 
samples were aspirated on a vacuum manifold, washed with three 200 
lal aliquots of ice-cold binding buffer. Binding data were analyzed 
using the non-linear regression curve-fitting program RS/I (BBN Soft- 
ware Products Corp., Cambridge, MA). 
Rabbit antisera were generated against he human Y4/PP1 receptor 
carboxy-terminal 17-mer peptide coupled to keyhole limpet hemocya- 
nin. Total homogenates (40 lag protein) of human tissues were frac- 
tionated on SDS-polyacrylamide g ls (4-20%), transferred onto nitro- 
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cellulose membranes and probed with antisera diluted in non-fat milk 
(1 : 100). Alkaline phosphatase conjugated goat anti-rabbit antibody 
and color development reagent were from Immun-Blot Assay Kit 
(Bio-Rad Labs). 
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Fig. 3. Southern blot analysis of EcoRI-digested genomic DNA, 
using a mouse NPYR-D probe under moderate stringency. Each of 
the species examined revealed a single hybridizing band likely repre- 
senting the NPYR-D gene species homologues. This blot was 
stripped and re-probed with a human Y4/PP1 receptor probe. The 
arrow indicates the position of the human Y4/PPI receptor gene 
EeoRI fragment, which was detected by hybridization under high 
stringency conditions. Similar data were also obtained with BamHI- 
digested genomic DNA. 
3. Results and discussion 
To find genes that encode novel members of the NPY re- 
ceptor family, a mouse genomic library was screened with a 
radiolabeled 53-mer oligonucleotide corresponding to the se- 
venth transmembrane region (TM7) of the cloned NPY recep- 
tors. Two genomic clones 0~MM-37 and ~,MM-51) were 
found to contain a novel gene named NPYR-D. A 6 kb frag- 
ment of ~,MM-37 was subcloned, and sequencing identified 
the entire open reading frame of NPYR-D. No evidence for 
introns was found in the coding region of NPYR-D; this is 
not surprising, since many G protein coupled receptors are 
known to be intronless. 
Sequence analysis of NPYR-D revealed a l125-bp open 
reading frame encoding 375 amino acid residues with a calcu- 
lated molecular mass of 42,634 Da (Fig. 1). The sequence 
around the predicted initiator methionine codon agrees with 
the consensus sequence and this methionine codon is preceded 
by an in-frame stop codon. Analysis of NPYR-D protein for 
regional hydrophobicity revealed seven putative transmem- 
brane domains (TMs), the typical hallmark of G protein 
coupled receptors. There are 5 potential N-linked glycosyla- 
tion sites, 3 in the N-terminus and 2 in the second extracel- 
lular loop connecting TMIV and TMV. The NPYR-D protein 
contains residues conserved in many G protein receptors, in- 
cluding an acidic residue in TMI I  and cysteine residues in the 
first and second extracellular loop which may form a disulfide 
bridge [22]. The carboxyl terminal region contains 7 serines 
and 3 threonines which may be substrates for protein kinases; 
phosphorylation has been implicated in receptor desensitiza- 
tion [23]. The C-terminus also contains cysteine residues 
which may be sites for fatty acid modification [24]. 
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Fig. 4. Comparison of competition curves for various peptides in transiently expressed NPYR-D membranes, using (A) []25I]rat PP and (B) 
[125I]PYY. Competing peptides were rPP (empty circles), hPP (filled circles), NPY (empty squares), PYY (filled squares), (Leu31pro34)NPY 
(empty triangles) and (2-36)NPY (filled triangles). Binding conditions are described in section 2. 
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Table 1 
Comparison of IC50 values for various peptides from [12~I]rPP and 
[125I]pYY binding to COS-7 cell membranes transiently expressing 
NPYR-D receptors. Values are the average of at least 2 independent 
experiments. 
PEPTIDE IC50 (nM) 
[125I]rPP [125I]pYY 
human PP (hPP) 0.054 0.11 
rat PP (rPP) 
(Leu 31Pro34)Npy 
0.097 0.11 
4 0.35 
PYY 500 3 
NPY 790 3 
2350 (2-36)NPY 83 
During the course of this work we became aware that the 
cloning and characterization f human and rat Y4/PP1 recep- 
tors have been presented in a preliminary form [17,19,20]. 
Comparison of the NPYR-D sequence (Fig. 2) with these 
sequences howed that NPYR-D has 92% identity to rat 
Y4/PP1 receptor and 76% identity to human Y4/PP1 receptor. 
Additional comparisons revealed 45% identity with the cloned 
Y1 receptor [13 15] and lower, 32% identity, with the cloned 
Y2 receptor [16,18]. A drosophila NPY receptor [25] has only 
28% identity with NPYR-D, and unrelated G protein recep- 
tors have approximately 25-31% identity with NPYR-D. 
Since mouse NPYR-D and human Y4/PP1 receptor pro- 
teins are 76% identitical and species homologs are typically 
A / 
9.5 
7.5 
4.4- 
2.4" 
1.35" 
C 
99bp- . .~  
61 
highly similar (>90% amino acid identity), we have investi- 
gated whether these two genes are species homologues. South- 
ern blot analysis of mouse and human genomic DNA with 
NPYR-D and Y4/PP1 probes suggested the existence of a 
single gene in both species. Cross-hybridization with mouse 
NPYR-D probe suggested that its human species homologue 
is indeed the human Y4/PP1 receptor gene (Fig. 3). The some- 
what unexpected lower homology may indicate substantial 
structural and functional divergence of these receptors. 
The coding region of NPYR-D was cloned into the expres- 
sion vector pcDNA3 and the resultant plasmid pG25 was 
transfected into COS-7 cells. Binding of [125I]rPP to mem- 
branes transiently transfected with NPYR-D was very high, 
indicating that PP may be the endogenous ligand for this 
mouse clone. Typically, greater than 95% specific binding 
was observed with [125I]rPP, while [12~I]PYY had only 50% 
specific binding at best. Of the peptides tested, both rat and 
human PP had the highest affinity for NPYR-D. Surprisingly, 
there were pharmacological differences observed when com- 
paring the pharmacological profiles for both radioligands 
(Fig. 4A,B). Of particular note were the affinities for NPY 
and PYY, which were only 25-fold weaker than rPP when 
[x%I]PYY was the radioligand, as compared to more than a 
5,000-fold difference when [125I]rPP was used (Table 1). A 
possible reason for this discrepancy between radioligands 
could be due to differences in affinity states recognized by 
[125I]rPP and [125I]pYY. 
Northern analysis of mouse and human tissues was per- 
formed to examine transcript sizes and regional differences 
in mRNA abundance. In the mouse, NPYR-D appears to 
B o / 
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1.35 
13-actin- 
Fig. 5. Tissue distribution of NPYR-D and its human homologue. (A) Northern analysis of NPYR-D message in various mouse tissues. Blot 
contains about 2 gg of poly(A) + RNA from various mouse tissues. (B) Northern analysis of human Y4/PP1 receptor message in various human 
tissues. Blot (B) contains 2 gg of poly(A) + RNA from human tissues. (C) Expression of human Y4/PP1 receptors assesed by RT-PCR. Lane 1, 
brain; 2, spinal cord; 3, hippocampus; 4, cerebellum; 5, hypothalamus; 6, thalamus, 7, pituitary; 8, water. 
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~205kDa 
~140kDa 
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Fig. 6. Western blot analysis of human colon, small intestine and li- 
ver proteins with an antisera gainst C-terminus of human Y4/PPI 
receptors. Arrow points to the 43 kDa band which is likely to re- 
present the human Y4/PP1 receptor. 
be synthesized as a 4.2 kb message in the heart (Fig. 5A). This 
message could also be detected in the small intestine (data not 
shown) but not in brain and other tissues examined (Fig. 5A). 
The human homologue of NPYR-D was detected as a 5.9 kb 
transcript in the small intestine, colon, prostate (Fig. 5B) and 
stomach (not shown). Consistent with these observations, 
Western blot analysis with an antiserum against the car- 
boxy-terminus of the human Y4/PP1 receptor detected a 43 
kDa protein in human colon and small intestine (Fig. 6). At 
lower levels, using RT-PCR, the NPYR-D message was also 
detectable in various parts of the human brain (Fig. 5C). This 
tissue distribution is consistent with previously reported ef- 
fects of PP on gastrointestinal tract, such as ion transport in 
small intestine and colon, and gastrointestinal motility [5 7]. 
Expression in the CNS is consistent with brainstem-mediated 
effects of PP on gastrointestinal motility and gastric acid and 
pancreatic secretion [8-10]. The potential role of PP and its 
receptor in the brain may deserve further examination. 
The results presented here demonstrate hat the NPYR-D 
gene is coding for a novel PP receptor. The receptor also has 
an affinity for PYY and NPY, raising the possibility that this 
receptor may be shared by all three pancreatic polypeptides. 
The availability of cloned receptors hould aid in the search 
for specific antagonists, which are required for functional 
characterization f pancreatic polypeptides as well as for de- 
velopment of potential therapeutics. 
Note added in proof 
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